Prognosis evaluation in alpha-fetoprotein negative hepatocellular carcinoma after hepatectomy: Comparison of five staging systems

European Journal of Surgical Oncology

Volumn 36, Issue 8, 2010, Pages 718-724

  Zhang, X F ^a   Qi, X ^a   Meng, B ^a   Liu, C ^a   Yu, L ^a   Wang, B ^a   Lv, Y ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Alpha fetoprotein; Hepatocellular carcinoma; Prognosis; Staging system; Surgery

Indexed keywords

ALPHA FETOPROTEIN; HEPATITIS B SURFACE ANTIGEN; AFP PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; EVALUATION; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SCORING SYSTEM; TUMOR RECURRENCE; TUMOR VOLUME; AGED; CHEMISTRY; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; LIVER TUMOR; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; PREDICTION AND FORECASTING; RISK ASSESSMENT;

ADULT; AGED; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; KAPLAN-MEIERS ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 77954904529     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2010.05.022     Document Type: Article

References (28)

1. D.M. Parkin, F. Bray, and J. Ferlay Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74
2. G.I. Abelev Alpha-fetoprotein in ontogenesis and its association with malignant tumors Adv Cancer Res 14 1971 295
3. M.E. Alpert, J. Uriel, and B. de Nechaud Alpha-1 fetoglobulin in the diagnosis of human hepatoma N Engl J Med 278 1968 984
4. E.N. Debruyne, and J.R. Delanghe Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications Clin Chim Acta 395 2008 19
5. F. Trevisani, P.E. D'Intino, and A.M. Morselli-Labate Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status J Hepatol 34 2001 570
6. S.J. Han, S. Yoo, and S.H. Choi Actual half-life of alpha-fetoprotein as a prognostic tool in pediatric malignant tumors Pediatr Surg Int 12 1997 599
7. The Cancer of the Liver Italian Program (CLIP) Investigators A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients Hepatology 28 1998 751
8. X.F. Zhang, B. Meng, and X. Qi Prognostic factors after liver resection for hepatocellular carcinoma with hepatitis B virus-related cirrhosis: surgeon's role in survival Eur J Surg Oncol 35 6 2009 Jun 622 628
9. K. Hanazaki, S. Kajikawa, and N. Koide Prognostic factors after hepatic resection for hepatocellular carcinoma with hepatitis C viral infection: univariate and multivariate analysis Am J Gastroenterol 96 2001 1243
10. F.L. Greene, D.L. Page, and I.D. Fleming American Joint Committee on cancer staging manual 6th ed. 2002 Springer New York p. 131-44
11. K. Okuda, T. Ohtsuki, and H. Obata Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients Cancer 56 1985 918
12. J.M. Llovet, C. Bru, and J. Bruix Prognosis of hepatocellular carcinoma: the BCLC staging classification Semin Liver Dis 19 1999 329
13. C.S. Cho, M. Gonen, and J. Shia A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma J Am Coll Surg 206 2008 281
14. M. Kudo, H. Chung, and Y. Osaki Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan integrated staging score (JIS score) J Gastroenterol 38 2003 207
15. F. Farinati, D. Marino, and M. De Giorgio Diagnostic and prognostic role of α-fetoprotein in hepatocellular carcinoma: both or neither? Am J Gastroenterol 101 2006 524
16. R.A. Murgita, E.A. Goidl, and S. Kontianen Alpha-fetoprotein induces suppressor T cells in vitro Nature 267 1977 257
17. S. Yachnin, K. Soltani, and E.P. Lester Further studies on the mechanism of suppression of human lymphocyte transformation by human alpha-fetoprotein J Allergy Clin Immunol 65 1980 127
18. J. Bruix, M. Sherman, and J.M. Llovet Clinical management of hepatocellular carcinoma. Conclusion of the Barcelona - 2000 EASL conference J Hepatol 35 2001 421
19. J. Bruix, and J.M. Llovet Prognostic prediction and treatment strategy in hepatocellular carcinoma Hepatology 35 2002 519
20. F. Orlandi, and E. Christensen A consensus conference on prognostic studies in hepatology J Hepatol 30 1999 171
21. J.M. Llovet, and J. Bruix Letter to the editor Hepatology 32 2000 679
22. J. Marrero, R. Fontana, and A. Barrat Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort Hepatology 41 2005 707
23. U. Cillo, A. Vitale, and F. Grigoletto Prospective validation of the Barcelona Clinic Liver Cancer staging system J Hepatol 44 2006 723
24. H. Chung, M. Kudo, and S. Takahashi Comparison of three current staging systems for hepatocellular carcinoma: Japan integrated staging score, new Barcelona Clinic Liver Cancer staging classification, and Tokyo score J Gastroenterol Hepatol 23 2008 445
25. A. Grieco, M. Pompili, and G. Caminiti Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre Gut 54 2005 411
26. J. Bruix, and M. Sherman Practice Guidelines Committee, American association for the Study of Liver Diseases. Management of hepatocellular carcinoma Hepatology 42 2005 1208
27. G. Torzilli, M. Donadon, and M. Marconi Hepatectomy for stage B and stage C hepatocellular carcinoma in the Barcelona Clinic Liver Cancer classification: results of a prospective analysis Arch Surg 143 2008 1082
28. J.N. Vauthey, G.Y. Lauwers, and N.F. Esnaola Simplified staging for hepatocellular carcinoma J Clin Oncol 20 2002 1527